Imodium (Loperamide Hydrochloride)

Loperamide acts as a peripheral μ‑opioid receptor agonist in the gut. By binding to these receptors, it decreases smooth‑muscle activity, prolongs intestinal transit time, and enhances fluid absorption, which collectively reduces the volume and frequency of watery stools.

The appropriate dose of Imodium is determined by a healthcare professional based on the individual’s age, condition severity, and response to therapy. Patients should follow the prescriber’s instructions and the product labeling for safe use.

The safety of Imodium in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks before prescribing it to pregnant or nursing individuals.

To place an order, submit an enquiry on the Imodium product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Imodium (loperamide) is a peripheral μ‑opioid receptor agonist, whereas other agents like diphenoxylate‑atropine also act on opioid receptors but have central activity. Loperamide generally has a lower risk of central nervous system effects and is widely available over the counter in many regions.

Imodium should be stored at ambient temperature, below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain product stability.

Imodium is taken orally, usually as a tablet swallowed whole with water. The exact administration schedule, including the number of tablets and timing, should be directed by a prescriber based on the patient’s specific condition.

Serious risks include paralytic ileus, a severe bowel obstruction, and cardiac arrhythmias, especially when taken in high doses or combined with certain drug interactions. Patients should seek immediate medical attention if they experience severe abdominal pain, vomiting, or irregular heartbeats.

Imodium should not be used by individuals with known bacterial infections causing diarrhea (e.g., dysentery), those with acute ulcerative colitis, or patients with a history of severe constipation. Children under two years of age should also avoid using this medication unless specifically directed by a clinician.